This News Just Put Fulgent at the Top of My Buy List
An acquisition and raised guidance have reinforced the bull case for the stock.
Stay updated with breaking news from Inform Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An acquisition and raised guidance have reinforced the bull case for the stock.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
(RTTNews) - Shares of Fulgent Genetics, Inc. (FLGT) gained nearly 5% in extended trading session on Monday after the company announced the acquisi...
As the first installment of this two-part series shows, the future of AI and machine learning in healthcare doesn’t belong to one vendor.
/PRNewswire/ -- Force Therapeutics, the leading patient engagement platform and research network, announced today that Greg Andreola has joined its leadership...